113 results

• Nesina Leads Similar Diabetes Drugs in Adverse Events: Report

  April 17, 2014

  Irvin Jackson

  A look at diabetes drug adverse event reports suggests Nesina is the most dangerous and finds evidence of pancreatic cancer risks.

• Diabetes Drug Pancreatic Cancer Risk Questioned by FDA, EMA

  February 27, 2014

  Irvin Jackson

  The FDA and EMA say they can find no link between certain diabetes drugs and pancreatic cancer, despite other studies to the contrary.

• Hormone Replacement Therapy (HRT) Linked to Pancreatitis Risk: Study

  January 31, 2014

  Irvin Jackson

  HRT drugs may be linked to an increased risk of pancreatitis, a new study warns

• Byetta, Januvia Lawyers Meet with MDL Judge

  January 16, 2014

  Austin Kirk

  A conference today regarding pancreatic cancer lawsuits involving Byetta, Januvia and similar diabetes drugs will tackle key issues regarding the litigation.

• Science Day Scheduled in MDL for Januvia, Byetta Pancreatic Cancer

  December 2, 2013

  Austin Kirk

  The science behind diabetes, the drugs that treat it, and pancreatic cancer will be the subject of an upcoming science day involving litigation over Byetta and Januvia.

• Link Between Byetta, Januvia and Pancreatic Damage Confirmed by Study

  November 26, 2013

  Irvin Jackson

  A new study provides further evidence of the link between a risk of pancreatic damage and use of increatin mimetic diabetes drugs.

• Byetta, Januvia Attorneys Assigned to Leadership Roles in Federal MDL

  October 24, 2013

  Austin Kirk

  Attorneys have been appointed to leadership roles as incretin mimetic pancreatic cancer lawsuits move forward.

• Lawyers Seek Leadership Roles in Byetta, Januvia Cancer Litigation

  October 11, 2013

  Austin Kirk

  Attorneys seek leadership roles in MDL established for Byetta, Victoza, Janumet and Januvia lawsuits.

• Initial Conference Scheduled in MDL for Byetta, Januvia Cancer Lawsuits

  September 27, 2013

  Austin Kirk

  Lawyers involved in the pancreatic cancer lawsuits involving Byetta, Januvia, Janumet and Victoza are scheduled to meet with MDL judge on October 17.

• No Heart Benefits Or Risks Found in Onglyza or Nesina Diabetes Drugs

  September 4, 2013

  Irvin Jackson

  A new study appears to show that some diabetes drugs neither increase the risk of heart problems or prevent them.